A Stanford researcher explains that genome-wide association studies of psychiatric disorders are far more reliable than older, smaller genetic studies.
Stanford researchers have developed a technique to encourage the immune system to target a section of the flu virus that is conserved year to year.
In response to views that cigarettes were unhealthful, tobacco companies used images of medical professionals to sell their products.
Construction crews are putting the finishing touches on the new Stanford Hospital, getting ready for it to open later this year.
Inspired by his son's illness, Ron Davis and colleagues have discovered a diagnostic test for chronic fatigue syndrome, a notoriously elusive disease.
High performance CPR, which eliminates unnecessary pauses and utilizes a team approach, is thought to improve survival rates.
New guidelines offer teens and young adults practical tips on how to safely and constructively interact on social media about suicide.
Poet and radio host Al Letson explores the art and power of listening with medicine students at Stanford's Medicine and the Muse symposium.
Millions of people are at risk from inadequate or unreliable lighting during surgery, so a Stanford surgeon is part of a team developing an affordable surgical headlamp.
Auriel August, a resident in surgery, shares her story about why she decided to become a surgeon and her experience at Stanford.
A Stanford study has found that mandated public disclosure of physicians' financial ties may have diminished trust in all physicians.
After beginning her training in clinical reasoning, a first-year medical student considers the similarities between doctors and detectives.
Scientists at Stanford and beyond are working toward a new type of tuberculosis diagnostic that utilizes blood samples.
At a recent Dean's Lecture Series, Dean Lloyd Minor discussed organizational culture and diversity with Emma Walmsley, CEO of GlaxoSmithKline.
A radio show features a Stanford oncologist discussing ultra-fast "flash" radiation therapy, which may kill cancer cells with less collateral damage.
Ahead of the Big Data in Precision Health conference, Emma Huang from Johnson & Johnson Innovations discusses collaborations between industry and academia.